Catalyst Wire Dossier Catalyst Wire Dossier

Episalvan

Betulae cortex · Amryt AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Episalvan, covering 2022-07-15 to 2022-07-15. Get the full timeline:

Most recent: EMA Withdrawn: Episalvan (Betulae cortex) — Amryt AG

See pricing